Please check your internet connection and try again.
# Potassium Chloride
## Overview
Potassium chloride (KCL) is an electrolyte supplement used to prevent or treat hypokalemia.
## Primary Indications
* Prevention and treatment of hypokalemia.
* Potassium supplementation in patients receiving diuretics that cause potassium loss.
## Adult Dosing
* **Prevention of Hypokalemia:** Typically 20 mEq (1.5 g) once daily.
* **Treatment of Hypokalemia:** Dosing varies based on serum potassium levels and patient status.
* Mild hypokalemia: 40-100 mEq (3-7.5 g) per day divided in 2-4 doses.
* Severe hypokalemia or cardiac arrhythmias: May require IV administration, with doses up to 40 mEq (3 g) per hour, not to exceed 200 mEq (15 g) in 24 hours. **Intravenous administration should only be performed under strict medical supervision due to the risk of cardiac arrest.**
* Maximum oral dose: Typically 100 mEq (7.5 g) per day.
## Pediatric Dosing
* Dosing is highly individualized and depends on the child's age, weight, clinical condition, and serum potassium levels.
* **Prevention:** 1-2 mEq/kg/day (up to 40 mEq/day).
* **Treatment:** 2-5 mEq/kg/day (up to 40 mEq/day), often divided.
* **IV administration:** Refer to specific pediatric critical care protocols. **Extreme caution and continuous cardiac monitoring are required for IV potassium in pediatrics.**
## Dose Adjustments
* **Renal Impairment:** Dose reduction is necessary. Monitor serum potassium closely. Avoid in severe renal insufficiency.
* **Hepatic Impairment:** No specific dose adjustment, but monitor electrolytes closely.
## Contraindications
* Hyperkalemia.
* Conditions that predispose to hyperkalemia (e.g., severe renal impairment, untreated Addison's disease, severe burns, crush injuries, conditions causing extensive tissue breakdown).
* Certain gastrointestinal conditions (e.g., esophageal compression, delayed gastric emptying, intestinal obstruction, peptic ulceration) due to risk of gastrointestinal ulceration and bleeding with solid dosage forms.
## Adverse Effects
* **Gastrointestinal:** Nausea, vomiting, abdominal pain, diarrhea, flatulence, gastrointestinal bleeding, ulceration, perforation, and obstruction.
* **Cardiovascular:** Arrhythmias, cardiac arrest (especially with rapid IV infusion).
* **Other:** Hyperkalemia.
## Key Drug Interactions
* **Potassium-Sparing Diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia.
* **ACE Inhibitors and ARBs:** Increased risk of hyperkalemia.
* **NSAIDs:** May reduce the kaliuretic effect of potassium supplements and increase the risk of hyperkalemia.
* **Digitalis Glycosides:** Hypokalemia increases the risk of digitalis toxicity. Conversely, hyperkalemia may reduce the efficacy of digitalis.
* **Nephrotoxic Drugs:** Increased risk of hyperkalemia due to reduced renal excretion.
## Monitoring
* Serum potassium levels (baseline and periodically during therapy).
* Renal function (BUN, creatinine).
* ECG (especially with IV administration or suspected hyperkalemia).
* Signs and symptoms of hypokalemia and hyperkalemia.
* Gastrointestinal tolerance.
## Clinical Pearls
* Oral potassium chloride tablets should be taken with food or meals and a full glass of water to minimize gastrointestinal upset.
* Slow-release formulations may reduce gastrointestinal side effects but can be associated with intestinal blockage.
* Intravenous potassium administration must be done with extreme caution, usually through a central line, and with continuous cardiac monitoring. The rate of infusion should not exceed recommended limits.
* The exact dosing for severe hypokalemia, especially IV administration, is often guided by institutional protocols.
***
*Disclaimer: This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant guidelines for complete and up-to-date information.*
